Billionaires Holding AVEO

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 51.8M
    Shares Outstanding

  • 47.6M
    Market Cap

News & Insights

ABOUT

AVEO

Aveo Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. The Company's lead product candidate is an oral inhibitor of the vascular endothelial growth factor, or VEGF,receptors.

Apple And Berkshire Hathaway: When Two Worlds Collide

NEWS

Icahn: Best Bet On Commodities

READ MORE